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Marfan syndrome (MFS) is a hereditary disorder of the connective tissue that causes
life-threatening aortic aneurysm, which initiates at the aortic root and can progress into
the ascending portion. However, analysis of ascending aorta reactivity in animal models
of MFS has remained elusive. Epidemiologic evidence suggests that although MFS is
equally prevalent in men and women, men are at a higher risk of aortic complications
than non-pregnant women. Nevertheless, there is no experimental evidence to support
this hypothesis. The aim of this study was to explore whether there are regional and
sex differences in the thoracic aorta function of mice heterozygous for the fibrillin 1
(Fbn1) allele encoding a missense mutation (Fbn1C1039G/+), the most common class of
mutation in MFS. Ascending and descending thoracic aorta reactivity was evaluated by
wiremyography. Ascending aortamRNA and protein levels, and elastic fiber integrity were
assessed by qRT-PCR, Western blotting, and Verhoeff-Van Gieson histological staining,
respectively. MFS differently altered reactivity in the ascending and descending thoracic
aorta by either increasing or decreasing phenylephrine contractions, respectively. When
mice were separated by sex, contractions to phenylephrine increased progressively
from 3 to 6 months of age in MFS ascending aortas of males, whereas contractions in
females were unchanged. Endothelium-dependent relaxation was unaltered in the MFS
ascending aorta of either sex; an effect related to augmented endothelium-dependent
hyperpolarization-type dilations. In MFS males, the non-selective cyclooxygenase (COX)
inhibitor indomethacin prevented the MFS-induced enhancement of phenylephrine
contractions linked to increased COX-2 expression. In MFS mice of both sexes, the
non-selective nitric oxide synthase inhibitor L-NAME revealed negative feedback of nitric
oxide on phenylephrine contractions, which was associated with upregulation of eNOS in
females. Finally, MFS ascending aortas showed a greater number of elastic fiber breaks
than the wild-types, and males exhibited more breaks than females. These results show
regional and sex differences in Fbn1C1039G/+ mice thoracic aorta contractility and aortic
media injuries. The presence of more pronounced aortic alterations in male mice provides
experimental evidence to support that male MFS patients are at increased risk of suffering
aortic complications.
Keywords: Marfan syndrome, aortic aneurysm, sex differences, gender medicine, ascending thoracic aorta
contraction, cyclooxygenase, nitric oxide synthase, elastin fragmentation
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INTRODUCTION
Marfan syndrome (MFS) is an autosomal dominant hereditary
disorder of connective tissue that results from mutations
in the gene for fibrillin 1 (Fbn1), the major constitutive
element of extracellular microfibrils (Dietz et al., 1991). Aortic
complications, including severe aortic regurgitation or acute
aortic dissection, are potentially life threatening (Murdoch
et al., 1972). Prophylactic surgical repair of the ascending aorta
has extended life in MFS over the past decades, but as a
result, new features have emerged including aortic dilatation
beyond the aortic root (Pyeritz, 2016). Although, both ascending
and descending portions of thoracic aorta show mechanical
abnormalities in MFS (Chung et al., 2007b; Bellini et al.,
2016), aneurysmal expansion initiates at the aortic root and
progresses into the ascending portion. This sequence of events
could be at least partly associated with the more pronounced
mechanical alterations of this aortic region (Bellini et al., 2016).
Remarkably, exploration of the ascending portion of thoracic
aorta reactivity in murine models of MFS has remained elusive.
As far as we know, all vascular reactivity studies on aorta
have been conducted in the aortic arch or descending thoracic
portion, where compromised reactivity is reported (Chung et al.,
2007a,b,c, 2008; Yang et al., 2009, 2010a,b; Gibson et al., 2017).
Marfan syndrome (MFS) is equally prevalent in men
and women (Mueller et al., 2013). Epidemiological evidence
suggests that male patients with MFS have a higher risk of
an aortic event (aortic surgery or aortic dissection) than
females (Detaint et al., 2010; Franken et al., 2016; Groth et al.,
2017). Nevertheless, the mechanisms that promote higher
susceptibility to injury in males are not clear. Besides, pregnancy
is associated with an increased risk of aortic dissection in MFS
(Elkayam et al., 1995; Goland and Elkayam, 2009; Wanga et al.,
2016). The pregnancy-induced myriad of aortic wall changes
triggered by variations in hormone concentrations (Manalo-
Estrella and Barker, 1967) and the altered hemodynamic load
(Elkayam and Gleicher, 1998) could jointly render the aorta
more susceptible to injury. However, it is unknown whether
preexistent aortic alterations may predispose MFS females
toward injury during pregnancy. Notably, no studies to date
have directly attempted to examine the influence of sex on aortic
disease in animal models of Marfan syndrome. These studies are
fundamental to comprehend the complex pathophysiological
mechanisms underlying aortic pathology in Marfan
syndrome.
The efficacy and safety of pharmacological treatments in
MFS is under investigation. An effective approach is the
prophylactic surgical repair of the dilated ascending aorta, which
involves non-negligible risks. Therefore, it is mandatory to go
from bedside to bench for improved understanding of MFS
pathogenesis, to uncover new potential effective pharmacological
strategies, particularity for the management of both aortic
root and ascending aorta dilatation. To this aim, the present
study sought to examine whether there are regional and sex
differences in thoracic aorta reactivity of mice heterozygous for
the Fbn1 allele encoding a missense mutation (Fbn1C1039G/+);
the most common class of mutation in Marfan syndrome. The
Fbn1C1039G/+ mice develop progressive aortic dilatation starting
at about 2months of age, and althoughmice rarely die from aortic
dissection, they recapitulate most of the aortic complications
observed in human MFS (Judge et al., 2004; Lee et al., 2016).
METHODS
Animals
Fbn1C1039G/+ (Marfan)male and femalemice and their wild-type
littermates were obtained from The Jackson Laboratory/Charles
River (Lyon, France). All mice were housed according to
institutional guidelines (constant room temperature at 22◦C,
12 h: 12 h light-dark cycle, 60% humidity, and access to
food and water ad libitum). Experiments were conducted
under the guidelines established by Spanish legislation (RD
1201/2005). They were approved by the Ethics Committee of
the University of Barcelona, and were carried out in accordance
with the recommendations in European legislation (Directive
2010/63/EU).
Tissue Preparation
Segments of the ascending (vascular reactivity, mRNA levels,
elastin breaks and protein levels) and descending (vascular
reactivity) thoracic aorta were dissected (Figure 1A) free of fat
and connective tissue in ice-cold physiological salt solution (PSS;
composition inmM:NaCl 112.0; KCl 4.7; CaCl2 2.5; KH2PO4 1.1;
MgSO4 1.2; NaHCO3 25.0 and glucose 11.1) gassed with 95% O2
and 5% CO2.
Vascular Reactivity
Three-mo-old wild-type (male n = 5; female n = 5) and
Marfan (male n = 7; female n = 6) and 6-mo-old wild-
type (male n = 11; female n = 11) and Marfan (male n
= 12; female n = 10) mice were used. Segments (2mm)
of ascending and descending thoracic aorta were set up
on an isometric wire myograph (model 410A; Danish Myo
Technology, Aarhus, Denmark) filled with PSS (37◦C; 95% O2
and 5% CO2), as previously described (Onetti et al., 2013). The
vessels were stretched to 6 mN, as described (Chung et al.,
2007a), washed and allowed to equilibrate for 45min. The
tissues were contracted twice with 100mM KCl every 5min.
After washing, vessels were left to equilibrate for a further
30min before starting the experiments. Endothelial-dependent
vasodilatations to acetylcholine (ACh; 10−9–10−5 M) were
performed in 3 × 10−6 M phenylephrine (Phe)-precontracted
vessels. Contractile responses mediated by α1-adrenoceptor
stimulation were studied by evaluating Phe (10−9 to 3 × 10−5
M)-induced contraction. The effects of the non-selective nitric
oxide synthase (NOS) inhibitor Nω-nitro-l-arginine methyl ester
(L-NAME; 3× 10−4 M), the non-selective cyclooxygenase (COX)
inhibitor indomethacin (10−5 M), the intermediate (IKCa) and
large (BKCa)-conductance calcium-activated potassium channel
blocker charybdotoxin (100 nM), and the small-conductance
KCa (SKCa) channel blocker apamin (100 nM) were determined
by adding each treatment 30min before Phe- or ACh-induced
responses.
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FIGURE 1 | (A) Diagram illustrating the descending and ascending thoracic aorta segments used in the present study. Concentration-response curves to
phenylephrine in descending (B) and ascending (C,D) aorta from wild-type and Marfan syndrome mice. Results are the mean ± SE from wild-type (descending n =
10; ascending n = 10) and Marfan syndrome (descending n = 10; ascending n = 10–13) mice. *P < 0.05, **P < 0.01, ***P < 0.001 by two-way ANOVA.
Quantitative Real-Time PCR
A different set of 6-mo-old wild-type (male n = 15; female n =
14) and Marfan (male n = 15; female n = 13) mice was used.
mRNA expression was determined by quantitative real-time PCR
(qRT-PCR) using SYBER green detection, as described (Novensa
et al., 2010). Amounts of mRNA encoding COX-1, COX-2,
eNOS, and iNOS were expressed relative to Ribosomal Protein
S28 (Rps28), used as an internal control. qRT-PCR reactions were
set up following the manufacturer’s guidelines to SYBR green
master mix (Thermo Fisher Scientific, Waltham, MA USA).
Cycle threshold (Ct) values for each gene were referenced to the
internal control [comparative Ct (11Ct)] and converted to the
linear form relative to corresponding levels in sex-matched wild-
type levels (2−11Ct). Primer sequences for murine genes used in
this study are shown in Table 1.
Analysis of Protein Expression
Ascending aortic medial tissue from 6-mo-old wild-type (male
n = 6; female n = 6) and Marfan (male n = 6; female n =
6) mice was homogenized using a bullet blender, ø 0.9–2 and
3mm stainless steel beads (Next Advance, NY, USA) in 300
µl radioimmunoprecipitation assay buffer (RIPA, 10mM Tris-
HCl pH 7.5, 1mM EDTA pH 7.5, 0.5mM EGTA, 1% Triton X-
100, 0.1% sodium desoxycholate, 0.1% SDS, 140mM NaCl) and
protease inhibitors. Protein concentrations were assessed using a
colorimetric assay for protein concentration (Biorad, CA, USA).
Twenty micrograms of protein per sample were analyzed by 10%
TABLE 1 | Primer sequences for quantitative real-time PCR.
Gene
(accession number)
Sequence (5′ → 3′)
COX-1 F: GAGCCGTGAGATGGGTGGGAGGG
(NM_008969.3) R: TGGATGTGCAATGCCAACGGCT
COX-2 F: GTCAGGACTCTGCTCACGAAGGAAC
(NM_011198.3) R: ACAGCTCGGAAGAGCATCGCAG
eNOS F: TGTCACTATGGCAACCAGCGT
(NM_008713.4) R: GCGCAATGTGAGTCCGAAAA
iNOS F: TCAGCCACCTTGGTGAAGGGAC
(NM_010927.3) R: TAGGCTACTCCGTGGAGTGAACA
Rps28 F: TAGGGTAACCAAAGTGCTGGGC
(NM_016844) R: GACATTTCGGATGATAGAGCGG
(v/v) SDS-PAGE and transferred to nitrocellulose membranes.
Primary antibodies to COX-1 (Santa Cruz, CA, USA), COX-
2, eNOS, (p)eNOS (BD Transduction Laboratories, CA, USA),
iNOS (Thermo Fisher, MA, USA) and actin (Sigma Aldrich,
MO, USA) were incubated overnight in TBS 1% BSA. Protein
bands were revealed using secondary IgG HRP conjugates
(Promega, WI, USA) and Luminol Reagent together with
Hyperfilm (Amersham Pharmacia Biotech, Uppsala, Sweden).
Band intensities were measured by densitometry scanning using
ImageJ software (National Institute of Health, Bethesda, MD,
USA). Band intensities were relativized against actin as a loading
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control and the values of all groups were normalized forWTmale
average values.
Analysis of Elastin Breaks
An additional set of 6-mo-old wild-type (male n = 8; female
n = 7) and Marfan (male n = 8; female n = 8) mice was
used. The ascending thoracic aorta of mice was dissected,
rinsed and fixed in buffered formalin for 24 h, and posteriorly
embedded in paraffin. Five-micron aortic sections were stained
with Verhoeff-van Gienson (VVG) to visualize elastic fibers.
Slides were examined using an Olympus BX60 microscope. Four
representative VVG images of each mouse aorta were assessed
and two blinded observers counted the number of elastin breaks.
Statistics
All results are expressed as means ± SE of the number
(n) of mice indicated in the figure legends. Relaxations to
ACh are expressed as the percentage change from the Phe
precontracted level. Contractions to Phe are expressed as
a percentage of the tone generated by 100mM KCl. The
area under the curve was individually calculated from each
concentration-response curve to Phe and was expressed as
arbitrary units. Differences between concentration-response
curves were assessed by two-way repeated measures ANOVA
with Tukey’s post-test. Differences between area under the curve,
mRNA levels, elastin ruptures and protein expression were
assessed by regular two-way ANOVA with Tukey’s post-test.
Data analysis was carried out using GraphPad Prism, Version
5 (GraphPad Software, La Jolla, CA). A value of P < 0.05 was
considered significant.
RESULTS
Influence of Marfan Syndrome on Mice
Thoracic Aorta Reactivity
Contractile responses to KCl (100mM) were unaffected by MFS
in descending thoracic aortas (wild-type: 6.10 ± 0.87 mN, n =
10; Marfan: 6.23 ± 0.77 mN, n = 10) from 6-mo-old mice, and
ascending aortas from 3-mo-old (wild-type: 5.43± 0.60 mN, n=
10; Marfan: 4.91 ± 0.41 mN, n = 13) and 6-mo-old (wild-type:
5.09 ± 0.25 mN, n = 22; Marfan: 4.98 ± 0.31 mN, n = 22) mice.
The magnitude of the concentration-dependent contractions
evoked by Phe was higher in the ascending (Figures 1C,D) than
in the descending (Figure 1B) aorta. Phe-induced contractions
were higher in the ascending aorta of 3-(Figure 1C) and 6-
(Figure 1D) mo-old mice and decreased (P< 0.05; Figure 1B) in
the descending aorta of 6-mo-old MFS mice. Conversely, there
were no differences in endothelium-dependent ACh-induced
vasodilatation between wild-type and Marfan mice in both
thoracic aorta segments (results not shown).
Influence of Sex on Phe-Mediated
Contractions of Marfan Thoracic Aorta
We then separated mice by sex to examine whether MFS affects
the thoracic aorta reactivity of males and females differently. MFS
did not alter contractile responses to KCl in descending aortas
from 6-mo-old males (wild-type: 5.14± 0.96 mN, n= 5; Marfan:
5.31 ± 0.70 mN, n = 5) and females (wild-type: 7.05 ± 1.41
mN, n = 5; Marfan: 7.34 ± 1.40 mN, n = 5), or in ascending
aortas from 3-mo-old males (wild-type: 4.16 ± 0.30 mN, n =
5; Marfan: 4.93 ± 0.61 mN, n = 7) and females (wild-type:
6.70 ± 0.85 mN, n = 5; Marfan: 4.88 ± 0.60 mN, n = 6), and
ascending aortas from 6-mo-old males (wild-type: 4.92 ± 0.43
mN, n = 11; Marfan: 4.54 ± 0.42 mN, n = 12) and females
(wild-type: 5.25 ± 0.27 mN, n = 11; Marfan: 5.50 ± 0.42 mN,
n = 10). Contractions to Phe were similar in the wild-type mice
from either sex (Figures 2A–C). TheMarfan descending thoracic
aorta from 6-mo-old mice showed a trend (P = 0.059) toward
decreased contraction in males only (Figure 2A). Remarkably,
at either age, Phe-induced contractions in ascending aortas from
males were higher in MFS mice than in wild-type mice, whereas
contractions in females were unaffected (Figures 2B,C).
Influence of COX on Sex Differences in Phe
Contractions of Marfan Ascending Aorta
Considering that aneurysmal expansion in human MFS initiates
at the aortic root and progresses into the ascending portion,
we subsequently focused on the mechanisms mediating sex
differences in Marfan ascending aorta contractions from 6-mo-
old mice. Previous studies demonstrated that COX is involved
in the reactivity alterations of the Marfan descending thoracic
aorta (Chung et al., 2007c). In the Marfan ascending aorta, the
non-selective COX inhibitor indomethacin (10−5 M) reduced
(P < 0.05) Phe-induced contractions in mice from both sexes,
revealing a physiological COX-derived contractile influence
(Figures 2C, 3A). Interestingly, Phe-induced contractions after
indomethacin addition were similar in Marfan and wild-type
mice in either sex (Figures 3A,B). These results suggest that COX
activation underlies the Marfan-induced contractile alterations
in males. We then measured mRNA (Figure 3C) and protein
(Figure 3D) levels of COX isoforms. Although MFS significantly
increased COX-1 mRNA levels in either sex, protein expression
was unaffected. In contrast, mRNA and protein levels of COX-
2 were augmented (P < 0.05) in Marfan males, which suggests
that COX-2 was involved in the observed contractile alterations.
Note that COX-2 protein expression was higher in wild-type
females than in males, and MFS females showed reduced COX-2
expression.
Influence of NOS on Sex Differences in Phe
Contractions of Marfan Ascending Aorta
Marfan syndrome (MFS) is associated with increased basal levels
of NO (Yang et al., 2010b; Soto et al., 2016; Gibson et al.,
2017; Oller et al., 2017). Therefore, we next evaluated the effects
of the non-selective NOS inhibitor L-NAME (3 × 10−4 M)
that similarly potentiated (P < 0.001) Phe-induced contractions
in wild-type mice from both sexes (Figures 4A,B). The
observed Marfan-induced increase in Phe-induced contractions
(Figure 2C) in males was maintained after L-NAME addition
(Figure 4A). However, in the presence of L-NAME, the area
under the curve was greater (P < 0.01) in Marfan than in wild-
type mice (Figure 4B). In Marfan females, L-NAME addition
induced higher Phe-induced contractions than in the wild types
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FIGURE 2 | Concentration-response curves to phenylephrine in descending (A) and ascending (B,C) aorta from wild-type and Marfan syndrome male (left) and
female (right) mice. Results are the mean ± SE from wild-type (male descending n = 5; male ascending n = 5; female descending n = 5; female ascending n = 5) and
Marfan syndrome (male descending n = 5; male ascending n = 5–7; female descending n = 5; female ascending n = 5–6) mice. *P < 0.05, **P < 0.01, ***P < 0.001
by two-way ANOVA.
(Figure 4A), though the increased area under the curve did not
reach statistical significance (Figure 4B). These results suggest a
greater negative influence of NO on Phe-induced contractions in
either sex. Analysis of mRNA levels of NOS isoforms showed a
significant Marfan syndrome-dependent increase in eNOS and
iNOS in males and females, respectively (Figure 4C). However,
eNOS phosphorylation was only significantly increased (P <
0.01) in Marfan females, whereas eNOS and iNOS protein
expression remained unaltered in both groups (Figure 4D).
These results suggest that changes in eNOS activation account,
at least in part, for the increased NO negative influence on
Phe-induced contractions in Marfan females, while this effect in
Marfan males is not associated with changes in NOS expression.
Influence of Sex on ACh-Mediated
Relaxations of Marfan Ascending Aorta
Endothelium-dependent ACh-induced vasodilatation was
similar in ascending aortas from 3- (results not shown) and
6-(Figure 5A) mo-old mice. In addition, indomethacin did not
significantly modify ACh-mediated relaxation in either group
(results not shown). However, incubation of L-NAME (results
not shown) or L-NAME plus indomethacin (Figure 5B) to
isolate endothelium-dependent hyperpolarization (EDH)-type
dilation, showed higher aortic relaxations in Marfan than in
wild-type. Subsequent addition of the IKCa and BKCa channel
blocker charybdotoxin (100 nM) plus the specific SKCa channel
blocker apamin (100 nM) almost abolished ACh-evoked EDH-
type relaxations, and removed differences between Marfan and
wild-type mice (Figure 5C).
Influence of Sex on Ascending Aorta
Elastin Breaks in Marfan Syndrome
Fragmentation of elastin is an important component of
aneurysmal progression in Marfan syndrome. As expected, the
number of elastin breaks was higher (P< 0.001) in the ascending
aorta of MFS mice than wild-type mice (Figure 6). Furthermore,
sex influenced the occurrence of elastin breaks in Marfan
syndrome, since males showed a greater (P < 0.05) number of
breaks than females.
DISCUSSION
There are two key novel findings in this study. Firstly, Marfan
differentially affects ascending and descending portions of mice
thoracic aorta, as evidenced by increased or decreased Phe-
induced contractions, respectively. Secondly, sex differently
affects ascending aorta reactivity in Marfan syndrome, since
contractions only increased among males. Therefore, these
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FIGURE 3 | Concentration-response curves to phenylephrine (A) and analysis of area under the curve (B) in the presence of the non-selective cyclooxygenase (COX)
inhibitor indomethacin (Indo; 10−5 M) in ascending aorta from wild-type and Marfan syndrome male (left) and female (right) mice. Results are the mean ± SE from
wild-type (male n = 5; female n = 6) and Marfan syndrome (male n = 5; female n = 5) mice. (C) Comparative analysis of ascending aorta mRNA levels of COX
isoforms, COX-1 and COX-2. mRNA levels are expressed as 2−11Ct using Ribosomal Protein S28 as internal control. Results are the mean ± SE from wild-type
(male n = 13-15; female n = 14) and Marfan syndrome (male n = 13; female n = 12) mice. (D) Western blot analysis for COX-1 (left) and COX-2 (right) protein
expression. Bar graphs (bottom) show the results of densitometric analyses from pooled data. The molecular weight (kDa) of the protein is shown on the right side of
the blot. Results are the mean ± SE from wild-type (male n = 6; female n = 5–6) and Marfan syndrome (male n = 6; female n = 6) mice. *P < 0.05, **P < 0.01,
***P < 0.001 by two-way ANOVA.
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FIGURE 4 | Concentration-response curves to phenylephrine (A) and analysis of area under the curve (B) in the presence of the nonselective nitric oxide synthase
(NOS) inhibitor L-NAME (3 × 10−4 M) in ascending aorta from wild-type and Marfan syndrome male (left) and female (right) mice. Results are the mean ± SE from
wild-type (male n = 4; female n = 5) and Marfan syndrome (male n = 5; female n = 6) mice. (C) Comparative analysis of ascending aorta mRNA levels of NOS
isoforms, endothelial NOS (eNOS) and inducible NOS (iNOS). mRNA levels are expressed as 2−11Ct using Ribosomal Protein S28 as internal control. Results are the
mean ± SE from wild-type (male n = 15; female n = 13–14) and Marfan syndrome (male n = 14–15; female n = 12–13) mice. (D) Western blot analysis for eNOS
protein expression and phosphorylation at Ser-1177 (left), and iNOS protein expression (right). Bar graphs (bottom) show the results of densitometric analyses from
pooled data. The molecular weight (kDa) of the protein is shown on the right side of the blot Results are the mean ± SE from wild-type (male n = 3–6; female n = 3–6)
and Marfan syndrome (male n = 3–6; female n = 3–6) mice. *P < 0.05, **P < 0.01, ***P < 0.001 by two-way ANOVA.
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FIGURE 5 | Concentration-response curves to acetylcholine in the absence (A) or presence of L-NAME (3 × 10−4 M) plus Indo (10−5 M) (B) or L-NAME plus Indo
plus the IKCa and BKCa channel blocker charybdotoxin (Charybd; 100 nM) plus the specific SKCa channel blocker apamin (Apa; 100 nM) (C) in ascending aorta from
wild-type and Marfan syndrome male (left) and female (right) mice. Results are the mean ± SE from wild-type (male n = 4–6; female n = 5–6) and Marfan syndrome
(male n = 5–6; female n = 5–6) mice. *P < 0.05, **P < 0.01, ***P < 0.001 by two-way ANOVA.
results suggest the presence of regional and sex-related
differences in ascending aorta reactivity, which is likely to be
physiologically relevant in the management of thoracic aorta
disease in Marfan syndrome.
A general paradigm of MFS pathophysiology is that aortic
smooth muscle cells develop phenotypic alterations leading
to aortic wall weakening (Chung et al., 2007b; Crosas-Molist
et al., 2015). Previous studies reported that contractions of
the aortic arch and descending thoracic aorta are decreased in
Fbn1C1039G/+ mice (Chung et al., 2007a,b,c, 2008; Yang et al.,
2009, 2010a,b; Gibson et al., 2017). However, in the current
study, we demonstrate that MFS heterogeneously affects α1-
adrenergic contractions to Phe in aneurismal (ascending aorta)
and non-aneurysmal (descending aorta) tissue. Thus, whilst the
descending portion showed impaired Phe-induced responses,
we found that the ascending aorta, which is more prone to
developing aneurysm in Marfan syndrome, showed augmented
contractility. These results are consistent with those found in
a previous study that indicates greater expression of contractile
protein markers in human Marfan ascending aortas (Crosas-
Molist et al., 2015). Our findings reveal for the first time
the presence of regional differences in thoracic aorta reactivity
in a mouse model of Marfan syndrome. The results are in
agreement with mechanical abnormalities that have been found
to be more pronounced in the ascending aorta than in the
descending aorta in animal models of this pathology, which could
render the ascending segment more susceptible to aneurysmal
dilatation/rupture (Chung et al., 2007b; Bellini et al., 2016).
The underlying determinants of the regional differences could
be multiple, including differential mechanical loading that the
pulsatile cardiac cycle transmits to the aortic tree (Prokop et al.,
1970) and/or the different embryonic cell lineages of both aortic
segments (Ruddy et al., 2013). For instance, a difference in α1-
adrenergic receptor density, as reported in the canine thoracic
aorta (Griendling et al., 1984) or in the population of α1-
adrenergic receptor subtypes may create distinct environments
in the ascending and descending aorta for the development of
divergent functional alterations.
There is still controversy about whether MFS affects the
thoracic aorta of men and women differently. However,
epidemiological evidence suggests that Marfan males have a
higher risk of aortic complications (Detaint et al., 2010; Franken
et al., 2016; Groth et al., 2017). An important point is that the sex
of MFS mice has only rarely been reported in previous studies
of aortic reactivity. In the present study, we demonstrate that
Marfan ascending aortas from males show a progressive increase
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FIGURE 6 | Representative images (A) and analysis of elastic fiber breaks (B) in the tunica media of the ascending aorta from wild-type and Marfan syndrome male
and female mice. Scale bar represents 100µm. Representative examples of elastin breaks are indicated with arrows. Results are the mean ± SE from wild-type (male
n = 8; female n = 8) and Marfan syndrome (male n = 7; female n = 8) mice. *P < 0.05, ***P < 0.001 by two-way ANOVA.
in contractions from 3 to 6 months of age, whereas contractions
in females are unaltered in the same time frame. These results
provide the first evidence of sexual dimorphism in MFS thoracic
aorta reactivity. A potential explanation for our results is that the
MFS disease-causing mutation could have higher penetrance in
male than female ascending aortas. To this end, we evaluated
the influence of sex on elastin fragmentation as a measure
of aortic disease progression. Although all Marfan groups had
more elastic lamina breaks than the wild types, the breaks were
more numerous in males than in females. These results suggest
the presence of more pronounced aortic disease in 6-mo-old
Fbn1C1039G/+ male mice, which correlates with the functional
alterations that were observed. We cannot discard a protective
effect by estrogens in female Marfan mice. In fact, this effect
has been described in rat abdominal aortic aneurysms, where
male predominance for aneurysm is also reported, and estradiol-
treated rats exhibited smaller aneurysms (Ailawadi et al., 2004).
Aorta is a poorly innervated vessel that highly depends
on circulating catecholamines to maintain sympathetic activity.
We suggest that heightened α1-adrenergic receptor-dependent
contractions of male Marfan ascending aortas might be an
orchestrated response to excessive aortic enlargement. However,
at this stage, it is unclear whether maintenance of these
alterations may be beneficial in the long-term, as for instance:
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(i) sympathetic overactivity in cardiovascular disorders
(i.e. hypertension, myocardial infarction) is life threatening
(Grassi, 2010); (ii) sympathetic tone is chronically elevated
in human aging (Casey et al., 2012); and (iii) excessive
aortic vasoconstriction increases cardiac afterload, which can
be detrimental in MFS patients, particularly in the setting of
congestive heart failure.
The principal vascular cell type involved in MFS pathogenesis
is the smooth muscle cell (Crosas-Molist et al., 2015; Perrucci
et al., 2017). However, abnormalities of endothelial function
disrupt circulatory homeostasis, which could aggravate Marfan
syndrome-induced vascular damage. Impaired endothelium-
dependent vasodilation to ACh has been reported in Marfan
descending thoracic aortas of 3- and 6-mo-old mice (Chung
et al., 2007a). In the current study, relaxations to ACh
were unaltered in the ascending aorta of 6-mo-old Marfan
mice. Importantly, we noted that EDH-type relaxations were
augmented in Marfan animals from both sexes. In large conduit
arteries such as aorta, agonist-induced endothelium-dependent
relaxations involve both NO and prostacyclin, whereas EDH-
type relaxations are more potent in smaller vessels (Chataigneau
et al., 1999; Brandes et al., 2000; Takaki et al., 2008). Increased
EDH-type relaxations in microvessels could compensate for
endothelial abnormalities in cardiovascular disease (Shimokawa
and Urakami-Harasawa, 1999). Nevertheless, although much
less studied, EDH-type relaxations may also serve as a backup
mechanism for endothelial responses of mice thoracic aorta
(Shen et al., 2003; Csányi et al., 2012). Therefore, we propose
that EDH-dependent preservation of endothelium function in
MFS ascending aorta could be a plausible adaptive mechanism
to maintain endothelium-dependent relaxation.
Previous studies reported that impaired Phe-induced
contractions of the Marfan descending thoracic aorta are
associated with a shift toward reduced expression of COX-1 and
enhanced expression of COX-2 (Chung et al., 2007c). Notably, a
partly different scenario occurs in the Marfan ascending aorta,
in which COX-dependent increases in Phe-induced contractions
in males are coupled to exclusive upregulation of COX-2
expression. In contrast, COX-2 expression was reduced in
Marfan females, an effect that was not accompanied by changes
in Phe-induced contractions. Therefore, we could speculate
that increased COX-2-derived contractile prostanoids (Álvarez
et al., 2005) may participate, at least partly, in enlarged Phe
contractions in males. Besides, elevated COX-2 expression is
associated with increased metalloproteinase activation (Tsujii
et al., 1997), which in turn is associated with aortic elastic fiber
fragmentation and degradation in MFS (Chung et al., 2007b).
Consistently, increased COX-2 expression correlated with a
larger number of elastin breaks in the ascending aorta of Marfan
males than in Marfan females. The underlying driving force for
increased COX-2 expression is unclear, but it could be linked
to loss of vessel elasticity and increase in pulse wave velocity
of the Marfan thoracic aorta (Chung et al., 2007c). There is
accumulating evidence connecting excessive basal levels of NO
and Marfan syndrome-induced aortic pathology (Yang et al.,
2010b; Soto et al., 2016; Gibson et al., 2017; Oller et al., 2017).
Consistently, our results reveal increased participation of NO
as a negative modulator of Phe-induced contractions in Marfan
mice of either sex. Moreover, our findings provide evidence of
the potential source of altered NO generation in female Marfan
ascending aortas, where eNOS phosphorylation was upregulated.
These results are consistent with the protective effects of estrogen
on vascular function, which have been largely associated with
upregulated eNOS (Chambliss and Shaul, 2002). Interestingly,
a recent study has shown that dysregulated NO production via
iNOS plays an important role in MFS aortic dilatation (Oller
et al., 2017). Therefore, the participation of an iNOS-derived NO
pool in Marfan mice of either sex caused by increases in enzyme
activity should not be excluded.
Altogether, the results of the present study provide evidence
of regional and sex-related differences in thoracic aorta reactivity
in a representative model of Marfan syndrome. Increased α-
adrenergic contractions may render the ascending aorta of males
more sensitive to circulating catecholamines, which might be a
short-term adaptive functional response against excessive aortic
enlargement. Nevertheless, further studies are necessary to verify
whether these alterations can contribute to increased thoracic
aorta vulnerability in male MFS patients. The present study
suggests that the development of an effective drug treatment
against excessive aortic enlargement should consider these
functional divergences, which might open the door to safer and
more effective personalized therapy in Marfan syndrome.
AUTHOR CONTRIBUTIONS
FJ-A: conceived the study, designed and executed the
experiments, guided the experimental design, analyzed and
interpreted the data, wrote and revised the manuscript. GE
and EV: guided the experimental design, data analysis and
interpretation, read and revised the manuscript. AD, A-MS,
FB, TM, and LB: executed the experiments, data analysis and
interpretation, read and revised the manuscript. All authors gave
final approval of the manuscript to be published.
FUNDING
This work was supported by grants SAF2005-64136-R (to GE)
and SAF2014-56111-R (to EV and FJ-A) from the Ministerio de
Ciencia e Innovación (Spain), and 2014SGR574 (to EV and FJ-A)
from the Generalitat de Catalunya (Spain).
REFERENCES
Ailawadi, G., Eliason, J. L., Roelofs, K. J., Sinha, I., Hannawa, K. K.,
Kaldjian, E. P., et al. (2004). Gender differences in experimental aortic
aneurysm formation. Arterioscler. Thromb. Vasc. Biol. 24, 2116–2122.
doi: 10.1161/01.ATV.0000143386.26399.84
Álvarez, Y., Briones, A. M., Balfagón, G., Alonso, M. J., and Salaices, M. (2005).
Hypertension increases the participation of vasoconstrictor prostanoids from
cyclooxygenase-2 in phenylephrine responses. J. Hypertens. 23, 767–777.
doi: 10.1097/01.hjh.0000163145.12707.63
Bellini, C., Korneva, A., Zilberberg, L., Ramirez, F., Rifkin, D. B., and Humphrey,
J. D. (2016). Differential ascending and descending aortic mechanics parallel
Frontiers in Physiology | www.frontiersin.org 10 November 2017 | Volume 8 | Article 933
Jiménez-Altayó et al. Aortic Differences in Marfan Syndrome
aneurysmal propensity in a mouse model of Marfan syndrome. J. Biomech. 49,
2383–2389. doi: 10.1016/j.jbiomech.2015.11.059
Brandes, R. P., Schmitz-Winnenthal, F. H., Félétou, M., Gödecke, A., Huang, P.
L., Vanhoutte, P. M., et al. (2000). An endothelium-derived hyperpolarizing
factor distinct from NO and prostacyclin is a major endothelium-
dependent vasodilator in resistance vessels of wild-type and endothelial
NO synthase knockout mice. Proc. Natl. Acad. Sci. U.S.A. 97, 9747–9752.
doi: 10.1073/pnas.97.17.9747
Casey, D. P., Padilla, J., and Joyner, M. J. (2012). α-adrenergic
vasoconstriction contributes to the age-related increase in conduit
artery retrograde and oscillatory shear. Hypertension 60, 1016–1022.
doi: 10.1161/HYPERTENSIONAHA.112.200618
Chambliss, K. L., and Shaul, P. W. (2002). Estrogen modulation of endothelial
nitric oxide synthase. Endocr. Rev. 23, 665–686. doi: 10.1210/er.2001-0045
Chataigneau, T., Félétou, M., Huang, P. L., Fishman, M. C., Duhault, J., and
Vanhoutte, P. M. (1999). Acetylcholine-induced relaxation in blood vessels
from endothelial nitric oxide synthase knockout mice. Br. J. Pharmacol. 126,
219–226. doi: 10.1038/sj.bjp.0702300
Chung, A. W., Au Yeung, K., Cortes, S. F., Sandor, G. G., Judge, D. P., Dietz,
H. C., et al. (2007a). Endothelial dysfunction and compromised eNOS/Akt
signaling in the thoracic aorta during the progression of Marfan syndrome. Br.
J. Pharmacol. 150, 1075–1083. doi: 10.1038/sj.bjp.0707181
Chung, A. W., Au Yeung, K., Sandor, G. G., Judge, D. P., Dietz, H. C., and
van Breemen, C. (2007b). Loss of elastic fiber integrity and reduction of
vascular smooth muscle contraction resulting from the upregulated activities
of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm inMarfan
syndrome. Circ. Res. 101, 512–522. doi: 10.1161/CIRCRESAHA.107.157776
Chung, A. W., Yang, H. H., Radomski, M. W., and van Breemen, C.
(2008). Long-term doxycycline is more effective than atenolol to
prevent thoracic aortic aneurysm in marfan syndrome through the
inhibition of matrix metalloproteinase-2 and−9. Circ. Res. 102, e73–e85.
doi: 10.1161/CIRCRESAHA.108.174367
Chung, A. W., Yang, H. H., and van Breemen, C. (2007c). Imbalanced synthesis
of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises
vasomotor function of the thoracic aorta inMarfan syndrome. Br. J. Pharmacol.
152, 305–312. doi: 10.1038/sj.bjp.0707391
Crosas-Molist, E., Meirelles, T., López-Luque, J., Serra-Peinado, C., Selva, J.,
Caja, L., et al. (2015). Vascular smooth muscle cell phenotypic changes in
patients with Marfan syndrome. Arterioscler. Thromb. Vasc. Biol. 35, 960–972.
doi: 10.1161/ATVBAHA.114.304412
Csányi, G., Gajda, M., Franczyk-Zarow, M., Kostogrys, R., Gwozdz, P., Mateuszuk,
L., et al. (2012). Functional alterations in endothelial NO, PGI2 and EDHF
pathways in aorta in ApoE/LDLR−/− mice. Prostaglandins Other Lipid Mediat.
98, 107–115. doi: 10.1016/j.prostaglandins.2012.02.002
Detaint, D., Faivre, L., Collod-Beroud, G., Child, A. H., Loeys, B. L., Binquet,
C., et al. (2010). Cardiovascular manifestations in men and women carrying
a FBN1 mutation. Eur. Heart J. 31, 2223–2229. doi: 10.1093/eurheartj/ehq258
Dietz, H. C., Cutting, G. R., Pyeritz, R. E., Maslen, C. L., Sakai, L. Y., Corson, G.
M., et al. (1991). Marfan syndrome caused by a recurrent de novo missense
mutation in the fibrillin gene. Nature 352, 337–339. doi: 10.1038/352337a0
Elkayam, U., and Gleicher, N. (1998). “Hemodynamics and cardiac function
during normal pregnancy and the puerperium,” in Cardiac Problems in
Pregnancy, eds U. Elkayam andN. Gleicher (New York, NY:Wiley-Liss), 23–32.
Elkayam, U., Ostrzega, E., Shotan, A., and Mehra, A. (1995). Cardiovascular
problems in pregnant women with Marfan syndrome. Ann. Intern. Med. 123,
117–122. doi: 10.7326/0003-4819-123-2-199507150-00007
Franken, R., Groenink, M., de Waard, V., Feenstra, H. M., Scholte, A. J., van den
Berg, M. P., et al. (2016). Genotype impacts survival in Marfan syndrome. Eur.
Heart J. 37, 3285–3290. doi: 10.1093/eurheartj/ehv739
Gibson, C. P., Nielsen, C., Alex, R., Cooper, K., Farney, M., Gaufin, D., et al. (2017).
Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation
in a mouse model of Marfan syndrome associated aortic aneurysm. J. Appl.
Physiol. 123, 147–160. doi: 10.1152/japplphysiol.00132.2017
Goland, S., and Elkayam, U. (2009). Cardiovascular problems in
pregnant women with marfan syndrome. Circulation 119, 619–623.
doi: 10.1161/CIRCULATIONAHA.104.493569
Grassi, G. (2010). Sympathetic neural activity in hypertension and related diseases.
Am. J. Hypertens. 23, 1052–1060. doi: 10.1038/ajh.2010.154
Griendling, K. K., Sastre, A., and Milnor, W. R. (1984). Regional differences in
alpha 1-adrenoceptor numbers and responses in canine aorta. Am. J. Physiol.
247, H928–H935.
Groth, K. A., Stochholm, K., Hove, H., Kyhl, K., Gregersen, P. A., Vejlstrup, N.,
et al. (2017). Aortic events in a nationwide Marfan syndrome cohort. Clin. Res.
Cardiol. 106, 105–112. doi: 10.1007/s00392-016-1028-3
Judge, D. P., Biery, N. J., Keene, D. R., Geubtner, J., Myers, L., Huso, D. L.,
et al. (2004). Evidence for a critical contribution of haploinsufficiency in
the complex pathogenesis of Marfan syndrome. J. Clin. Invest. 114, 172–181.
doi: 10.1172/JCI200420641
Lee, L., Cui, J. Z., Cua, M., Esfandiarei, M., Sheng, X., Chui, W. A., et al.
(2016). Aortic and cardiac structure and function using high-resolution
echocardiography and optical coherence tomography in a mouse model of
Marfan syndrome. PLoS ONE 11:e0164778. doi: 10.1371/journal.pone.0164778
Manalo-Estrella, P., and Barker, A. E. (1967). Histopathologic findings in human
aortic media associated with pregnancy. Arch. Pathol. 83, 336–341.
Mueller, G. C., Stark, V., Steiner, K., von Kodolitsch, Y., Rybczynski, M.,
Weil, J., et al. (2013). Impact of age and gender on cardiac pathology in
children and adolescents with Marfan syndrome. Pediatr. Cardiol. 34, 991–998.
doi: 10.1007/s00246-012-0593-0
Murdoch, J. L., Walker, B. A., Halpern, B. L., Kuzma, J. W., and McKusick,
V. A. (1972). Life expectancy and causes of death in the Marfan
syndrome. N. Engl. J. Med. 286, 804–808. doi: 10.1056/NEJM197204132
861502
Novensa, L., Selent, J., Pastor, M., Sandberg, K., Heras, M., and Dantas,
A. P. (2010). Equine estrogens impair nitric oxide production and
endothelial nitric oxide synthase transcription in human endothelial
cells compared with the natural 17β-estradiol. Hypertension 56, 405–411.
doi: 10.1161/HYPERTENSIONAHA.110.151969
Oller, J., Méndez-Barbero, N., Ruiz, E. J., Villahoz, S., Renard, M., Canelas, L.
I., et al. (2017). Nitric oxide mediates aortic disease in mice deficient in the
metalloprotease Adamts1 and in a mouse model of Marfan syndrome. Nat.
Med. 23, 200–212. doi: 10.1038/nm.4266
Onetti, Y., Jiménez-Altayó, F., Heras, M., Vila, E., and Dantas, A. P. (2013).
Western-type diet induces senescence, modifies vascular function in non-
senescence mice and triggers adaptive mechanisms in senescent ones. Exp.
Gerontol. 48, 1410–1419. doi: 10.1016/j.exger.2013.09.004
Perrucci, G. L., Rurali, E., Gowran, A., Pini, A., Antona, C., Chiesa, R.,
et al. (2017). Vascular smooth muscle cells in Marfan syndrome aneurysm:
the broken bricks in the aortic wall. Cell. Mol. Life Sci. 74, 267–277.
doi: 10.1007/s00018-016-2324-9
Prokop, E. K., Palmer, R. F., andWheat, M. W. Jr. (1970). Hydrodynamic forces in
dissecting aneurysms. in vitro studies in a tygon model and in dog aortas. Circ.
Res. 27, 121–127. doi: 10.1161/01.RES.27.1.121
Pyeritz, R. E. (2016). Recent progress in understanding the natural and clinical
histories of the Marfan syndrome. Trends Cardiovasc. Med. 26, 423–428.
doi: 10.1016/j.tcm.2015.12.003
Ruddy, J. M., Jones, J. A., and Ikonomidis, J. S. (2013). Pathophysiology of
thoracic aortic aneurysm (TAA): is it not one uniform aorta? Role of
embryologic origin. Prog. Cardiovasc. Dis. 56, 68–73. doi: 10.1016/j.pcad.2013.
04.002
Shen, B., Ye, C. L., Ye, K. H., and Liu, J. J. (2003). Mechanism underlying
enhanced endothelium-dependent vasodilatation in thoracic aorta of
early stage streptozotocin-induced diabetic mice. Acta Pharmacol. Sin. 24,
422–428.
Shimokawa, H., and Urakami-Harasawa, L. (1999). “Importance of endothelium-
derived hyperpolarizing factor in human arteries,” in Endothelium-Derived
Hyperpolarizing Factor, ed P. M. Vanhoutte (Amsterdam: Harwood Academic
Publishers), 391–398.
Soto, M. E., Iturriaga Hernández, A. V., Guarner Lans, V., Zuñiga-
Muñoz, A., Aranda Fraustro, A., Velázquez Espejel, R., et al. (2016).
Participation of oleic acid in the formation of the aortic aneurysm in
Marfan syndrome patients. Prostaglandins Other Lipid Mediat. 123, 46–55.
doi: 10.1016/j.prostaglandins.2016.05.001
Takaki, A., Morikawa, K., Tsutsui, M., Murayama, Y., Tekes, E., Yamagishi, H.,
et al. (2008). Crucial role of nitric oxide synthases system in endothelium-
dependent hyperpolarization in mice. J. Exp. Med. 205, 2053–2063.
doi: 10.1084/jem.20080106
Frontiers in Physiology | www.frontiersin.org 11 November 2017 | Volume 8 | Article 933
Jiménez-Altayó et al. Aortic Differences in Marfan Syndrome
Tsujii, M., Kawano, S., and DuBois, R. N. (1997). Cyclooxygenase-2
expression in human colon cancer cells increases metastatic potential.
Proc. Natl. Acad. Sci. U.S.A. 94, 3336–3340. doi: 10.1073/pnas.94.
7.3336
Wanga, S., Silversides, C., Dore, A., de Waard, V., and Mulder, B. (2016).
Pregnancy and thoracic aortic disease: managing the risks. Can. J. Cardiol. 32,
78–85. doi: 10.1016/j.cjca.2015.09.003
Yang, H. H., Kim, J. M., Chum, E., van Breemen, C., and Chung, A.
W. (2009). Long-term effects of losartan on structure and function
of the thoracic aorta in a mouse model of Marfan syndrome.
Br. J. Pharmacol. 158, 1503–1512. doi: 10.1111/j.1476-5381.2009.
00443.x
Yang, H. H., Kim, J. M., Chum, E., van Breemen, C., and Chung, A. W.
(2010a). Effectiveness of combination of losartan potassium and doxycycline
versus single-drug treatments in the secondary prevention of thoracic aortic
aneurysm in Marfan syndrome. J. Thorac. Cardiovasc. Surg. 140, 305–312.e2.
doi: 10.1016/j.jtcvs.2009.10.039
Yang, H. H., van Breemen, C., and Chung, A. W. (2010b). Vasomotor dysfunction
in the thoracic aorta of Marfan syndrome is associated with accumulation of
oxidative stress. Vascul. Pharmacol. 52, 37–45. doi: 10.1016/j.vph.2009.10.005
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
The reviewer LAML and handling Editor declared their shared affiliation.
Copyright © 2017 Jiménez-Altayó, Siegert, Bonorino, Meirelles, Barberà, Dantas,
Vila and Egea. This is an open-access article distributed under the terms of
the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Physiology | www.frontiersin.org 12 November 2017 | Volume 8 | Article 933
